# Riluzole Effects on Hippocampus Biomarkers

> **NCT04630444** · EARLY_PHASE1 · COMPLETED · sponsor: **Mclean Hospital** · enrollment: 20 (actual)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** Riluzole

## Key facts

- **NCT ID:** NCT04630444
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-16
- **Primary completion:** 2019-03-16
- **Final completion:** 2019-03-16
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04630444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04630444, "Riluzole Effects on Hippocampus Biomarkers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04630444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*